Clinical Trial Update: Pravastatin to Prevent Preeclampsia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating pravastatin to prevent preeclampsia was terminated, and the study results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension in Pregnancy
• Preeclampsia

Drugs mentioned

• Pravastatin (pravastatin)

Snippet

Sponsor: The George Washington University Biostatistics Center | Conditions: Preeclampsia, Obstetric Labor Complications | Phase 3 | Status: TERMINATED | Results posted: 2025-12-23